Shareholders of Israeli technology firm Elbit last week approvedthe Haifa company's acquisition of the Elscintec ultrasound businessof Elscint, an Elbit subsidiary. Elbit proposed the acquisitionlate last year (SCAN 12/27/95). Elbit continues to study a
Shareholders of Israeli technology firm Elbit last week approved
the Haifa company's acquisition of the Elscintec ultrasound business
of Elscint, an Elbit subsidiary. Elbit proposed the acquisition
late last year (SCAN 12/27/95). Elbit continues to study a plan
to spin off Elbit into three separate firms, including one that
would consolidate the healthcare operations of Elbit and Elscint.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.
2 Commerce Drive
Cranbury, NJ 08512